About Us
Our People
Board of Directors
Our Product
In Development
Mission
Investors
Careers
Contact
Contact Us
Media Contact
Investor Contact
Investors
Investors Home
Stock Quote
Stock Information
Historical Stock Price
News Releases
Events and Presentations
SEC Filings
Analyst Coverage
Corporate Governance
Board of Directors
Charters & Code of Ethics
FAQs
Investor Contacts & Alerts
Investors Home
Stock Quote
News Releases
Events and Presentations
SEC Filings
Analyst Coverage
Corporate Governance
FAQs
Investor Contacts & Alerts
News Releases
Year
All Years
2021
2020
2019
2018
2017
2016
2015
2014
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
Jun 2, 2020
Evofem Announces Proposed Public Offering of Common Stock
May 22, 2020
U.S. FDA Approves Evofem Biosciences' Phexxi™ (lactic acid, citric acid and potassium bitartrate), the First and Only Non-Hormonal Prescription Gel for the Prevention of Pregnancy
- A New Class of Female-Controlled Birth Control for Use In-The-Moment -
May 13, 2020
Evofem Biosciences to Participate in Virtual Fireside Chat at RBC Capital Markets Global Healthcare Conference
May 6, 2020
Evofem Biosciences Reports First Quarter 2020 Financial Results and Provides Corporate Update
- On-Track for Phexxi™ PDUFA Date: May 25, 2020 -
May 1, 2020
Evofem Biosciences Announces New Location and COVID-19 Preventative Measures for 2020 Annual Meeting Scheduled for May 12, 2020
Show
5
10
25
50
100
per page
«
1
…
5
6
7
8
9
10
11
…
25
»